journal article·2023-04-06Open access

Tropoelastin-Pretreated Exosomes from Adipose-Derived Stem Cells Improve the Synthesis of Cartilage Matrix and Alleviate Osteoarthritis

Shuo Meng, Cong Tang, Muhai Deng, Jie Yuan, Yanli Fan, Shasha Gao, Yong Feng, Junjun Yang, Cheng Chen

Abstract

Mesenchymal stem cells (MSCs) have recently been widely used to treat osteoarthritis (OA). Our prior research shows that tropoelastin (TE) increases MSC activity and protects knee cartilage from OA-related degradation. The underlying mechanism might be that TE regulates the paracrine of MSCs. Exosomes (Exos), the paracrine secretion of MSCs, have been found to protect chondrocytes, reduce inflammation, and preserve the cartilage matrix. In this study, we used Exos derived from TE-pretreated adipose-derived stem cells (ADSCs) (TE-ExoADSCs) as an injection medium, and compared it with Exos derived from unpretreated ADSCs (ExoADSCs). We found that TE-ExoADSCs could effectively enhance the matrix synthesis of chondrocytes in vitro. Moreover, TE pretreatment increased the ability of ADSCs to secrete Exos. In addition, compared with ExoADSCs, TE-ExoADSCs exhibited therapeutic effects in the anterior cruciate ligament transection (ACLT)-induced OA model. Further, we observed that TE altered the microRNA expression in ExoADSCs and identified one differentially upregulated microRNA: miR-451-5p. In conclusion, TE-ExoADSCs helped maintain the chondrocyte phenotype in vitro, and promoted cartilage repair in vivo. These therapeutic effects might be related with the altered expression of miR-451-5p in the ExoADSCs. Thus, the intra-articular delivery of Exos derived from ADSCs with TE pretreatment could be a new approach to treat OA.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Extracellular vesicles in disease · Osteoarthritis Treatment and Mechanisms · Lower Extremity Biomechanics and Pathologies

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

College of Medical Informatics, Chongqing Medical University, Chongqing 400016, China

Department of Orthopaedic Surgery, Chongqing Emergency Medical Center, Chongqing University Central Hospital, Chongqing 400014, China

Key Laboratory of Biorheological Science and Technology, College of Bioengineering, Chongqing University, Ministry of Education, Chongqing 400044, China

Funding

Science and Technology Projects of Chongqing Education Commission · Natural Science Foundation of Chongqing · Future Medical Innovation Team of Chongqing Medical University · Student Scientific Research and Innovation Experiment Project of the School of Medical Information · Project of Innovative Science Research for Postgraduates of Chongqing Municipal Education Committee

References (44)

Show source-provided references
1. Knee Osteoarthritis: A Primer10.7812/TPP/16-183 ↗
2. Almonte-Becerril, M., Gimeno, L.I., Villarroya, O., Benito-Jardon, M., Kouri, J.B., and Costell, M. (2018). Genetic abrogation of the fibronectin-alpha5beta1 integrin interaction in articular cartilage aggravates osteoarthritis in mice. PLoS ONE, 13.10.1371/journal.pone.0198559 ↗
3. Deciphering osteoarthritis genetics across 826,690 individuals from 9 populations10.1016/j.cell.2021.07.038 ↗
4. Roseti, L., Desando, G., Cavallo, C., Petretta, M., and Grigolo, B. (2019). Articular Cartilage Regeneration in Osteoarthritis. Cells, 8.10.3390/cells8111305 ↗
5. Lindler, B.N., Long, K.E., Taylor, N.A., and Lei, W. (2020). Use of Herbal Medications for Treatment of Osteoarthritis and Rheumatoid Arthritis. Medicines, 7.10.3390/medicines7110067 ↗
6. Knee osteoarthritis: Key treatments and implications for physical therapy10.1016/j.bjpt.2020.08.004 ↗
7. Microfracture versus Drilling of Articular Cartilage Defects: A Systematic Review of the Basic Science Evidence10.1177/2325967120945313 ↗
8. Application of mesenchymal stem cell therapy for the treatment of osteoarthritis of the knee: A concise review10.4252/wjsc.v11.i4.222 ↗
9. Tissue Engineering and Regenerative Medicine 2019: The Role of Biofabrication-A Year in Review10.1089/ten.tec.2019.0344 ↗
10. Heterogeneity of mesenchymal stem cells in cartilage regeneration: From characterization to application10.1038/s41536-021-00122-6 ↗
11. New Insights into Cartilage Tissue Engineering: Improvement of Tissue-Scaffold Integration to Enhance Cartilage Regeneration10.1155/2022/7638245 ↗
12. Effect of self-assembled peptide-mesenchymal stem cell complex on the progression of osteoarthritis in a rat model10.2147/IJN.S54114 ↗
13. Human adipose-derived mesenchymal stem cells for osteoarthritis: A pilot study with long-term follow-up and repeated injections10.2217/rme-2017-0152 ↗
14. 3D in-vitro cultures of human bone marrow and Wharton’s jelly derived mesenchymal stromal cells show high chondrogenic potential10.3389/fbioe.2022.986310 ↗
15. Mesenchymal stem cells in osteoarthritis therapy: A review
16. Mazini, L., Rochette, L., Amine, M., and Malka, G. (2019). Regenerative Capacity of Adipose Derived Stem Cells (ADSCs), Comparison with Mesenchymal Stem Cells (MSCs). Int. J. Mol. Sci., 20.10.3390/ijms20102523 ↗
17. Clinical Application Status of Articular Cartilage Regeneration Techniques: Tissue-Engineered Cartilage Brings New Hope10.1155/2020/5690252 ↗
18. Immunomodulatory and Regenerative Effects of Mesenchymal Stem Cells and Extracellular Vesicles: Therapeutic Outlook for Inflammatory and Degenerative Diseases10.3389/fimmu.2020.591065 ↗
19. Cheng, J., Sun, Y., Ma, Y., Ao, Y., Hu, X., and Meng, Q. (2022). Engineering of MSC-Derived Exosomes: A Promising Cell-Free Therapy for Osteoarthritis. Membranes, 12.10.3390/membranes12080739 ↗
20. Exosomes derived from human umbilical cord blood mesenchymal stem cells stimulate regenerative wound healing via transforming growth factor-beta receptor inhibition10.1186/s13287-021-02517-0 ↗
21. Anti-inflammatory and immunomodulatory effects of the extracellular vesicles derived from human umbilical cord mesenchymal stem cells on osteoarthritis via M2 macrophages10.1186/s12951-021-01236-1 ↗
22. MicroRNA in osteoarthritis: Physiopathology, diagnosis and therapeutic challenge10.1093/bmb/ldz015 ↗
23. Porcine Platelet Lysate Intra-articular Knee Joint Injections for the Treatment of Rabbit Cartilage Lesions and Osteoarthritis10.1007/s40846-023-00776-1 ↗
24. Exosomes: Roles and therapeutic potential in osteoarthritis10.1038/s41413-020-0100-9 ↗
25. Mesenchymal Stem Cell-Derived Extracellular Vesicles Therapy for Pulmonary Hypertension: A Comprehensive Review of Preclinical Studies10.1155/2022/5451947 ↗
26. Zhang, B., Tian, X., Qu, Z., Hao, J., and Zhang, W. (2022). Hypoxia-Preconditioned Extracellular Vesicles from Mesenchymal Stem Cells Improve Cartilage Repair in Osteoarthritis. Membranes, 12.10.3390/membranes12020225 ↗
28. Soluble matrix protein is a potent modulator of mesenchymal stem cell performance10.1073/pnas.1812951116 ↗
29. Tropoelastin improves adhesion and migration of intra-articular injected infrapatellar fat pad MSCs and reduces osteoarthritis progression10.1016/j.bioactmat.2021.09.011 ↗
30. Review and comparison of culture-techniques for articular chondrocytes10.1055/s-2002-31532 ↗
31. The OARSI histopathology initiative—Recommendations for histological assessments of osteoarthritis in the rat10.1016/j.joca.2010.05.030 ↗
32. Biochemical and metabolic abnormalities in articular cartilage from osteo-arthritic human hips. II. Correlation of morphology with biochemical and metabolic data10.2106/00004623-197153030-00009 ↗
33. Synovitis score: Discrimination between chronic low-grade and high-grade synovitis10.1111/j.1365-2559.2006.02508.x ↗
34. miR-100-5p-abundant exosomes derived from infrapatellar fat pad MSCs protect articular cartilage and ameliorate gait abnormalities via inhibition of mTOR in osteoarthritis10.1016/j.biomaterials.2019.03.022 ↗
35. Human mesenchymal stem cells (MSCs) for treatment towards immune- and inflammation-mediated diseases: Review of current clinical trials10.1186/s12929-016-0289-5 ↗
36. Effects of donor age, gender, and in vitro cellular aging on the phenotypic, functional, and molecular characteristics of mouse bone marrow-derived mesenchymal stem cells10.1089/scd.2010.0280 ↗
37. Umbilical Cord-Derived Mesenchymal Stem Cell-Derived Exosomal MicroRNAs Suppress Myofibroblast Differentiation by Inhibiting the Transforming Growth Factor-beta/SMAD2 Pathway During Wound Healing10.5966/sctm.2015-0367 ↗
38. Intra-Articular Injections of Mesenchymal Stem Cell Exosomes and Hyaluronic Acid Improve Structural and Mechanical Properties of Repaired Cartilage in a Rabbit Model10.1016/j.arthro.2020.03.031 ↗
39. Bone marrow mesenchymal stem cell-derived exosomes protect cartilage damage and relieve knee osteoarthritis pain in a rat model of osteoarthritis10.1186/s13287-020-01781-w ↗
40. Exosome: A significant nano-scale drug delivery carrier10.1039/D0TB01499K ↗
41. Exosomes derived from mesenchymal stem cells inhibit mitochondrial dysfunction-induced apoptosis of chondrocytes via p38, ERK, and Akt pathways10.1007/s11626-019-00330-x ↗
42. Degeneration of the lumbar spine and its relation to the expression of collagen and elastin in facet joint capsules and ligament flavum10.5152/j.aott.2022.21314 ↗
43. Non-coding RNAs as regulators of gene expression and epigenetics10.1093/cvr/cvr097 ↗
44. LncRNA-p21 promotes chondrocyte apoptosis in osteoarthritis by acting as a sponge for miR-451